DexCom, Inc. (DXCM) is in Healthcare, Medical Devices, based in United States, listed on NasdaqGS. Market cap 32.11B USD. 52-week range 54.11 to 92.59 USD. Trailing P/E 33.8. Data as of 2026-10-09.
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with ...